Sections

JTA
EST 1917

Forbes labels Teva ‘superstar

Forbes included Israeli pharmaceutical firm Teva on its ranking of 130 “global superstars.”

Advertisement
Getting your Trinity Audio player ready...

Forbes included Israeli pharmaceutical firm Teva on its ranking of 130 “global superstars.” Ynet reported Monday that the Forbes shortlist, a lead-up to its annual “Global 2,000” ranking, is based on a combination of the firms’ sales, profits, assets and market value. In 2006, Teva registered $8.41 billion in sales, $55 million in profits, $20.47 billion in assets and a market value of $26.91
billion.

Recommended from JTA

Advertisement